studex®️ universal piercing instrument kit (r993-s) device
safe piercing medical equipments l.l.c. united states of america - 1 device kit (r993-s) - device - device - n/a
studex®️ universal piercing instrument kit (r993-s) device
safe piercing medical equipments l.l.c. united states of america - 1 device kit (r993-s) - device - device - n/a
studex®️ universal piercing instrument kit (r993-s) device
safe piercing medical equipments l.l.c. united states of america - 1 device kit (r993-s) - device - device - n/a
studex®️ universal piercing instrument kit (r993-s) device
safe piercing medical equipments l.l.c. united states of america - 1 device kit (r993-s) - device - device - n/a
studex®️ universal piercing instrument kit (r993-s) device
safe piercing medical equipments l.l.c. united states of america - 1 device kit (r993-s) - device - device - n/a
blincon owndays disposable cosmetic contact lens
gt consultancy & training services - ophthalmology - owndays disposable cosmetic contact lens is for correct visual acuity in aphakic and non-aphakic persons with non-diseased eyes with myopia. it is also meant for cosmetic purpose.
microaire smartrelease endoscopic soft tissue release system
far eastern medical - general hospital - the microaire smartrelease endoscopic soft tissue release system is indicated for use in minimally invasive ligament or fascia release: • carpal tunnel release in the wrist • cubital tunnel release in the elbow
carfilnat injection 60 mg/vial
natco pharma limited, india - carfilzomib - injection - 60 mg/vial
kyprolis carfilzomib 60 mg powder for injection vial
amgen australia pty ltd - carfilzomib, quantity: 60 mg - injection, powder for - excipient ingredients: sodium hydroxide; sulfobutyl betadex sodium; citric acid - kyprolis is indicated for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior therapy as part of combination therapy with: ? dexamethasone, or ? lenalidomide and dexamethasone, or ? daratumumab and dexamethasone, or ? isatuximab and dexamethasone
kyprolis carfilzomib 30 mg powder for injection vial
amgen australia pty ltd - carfilzomib, quantity: 30 mg - injection, powder for - excipient ingredients: sodium hydroxide; sulfobutyl betadex sodium; citric acid - kyprolis is indicated for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior therapy as part of combination therapy with: ? dexamethasone, or ? lenalidomide and dexamethasone, or ? daratumumab and dexamethasone, or ? isatuximab and dexamethasone